GM-CSF is largely produced in RA by sub-lining CD90+ FAP+ synovial fibroblasts, CD90+ activated endothelium, and CD163+ MP and represents another activating cytokine for MP [72]. The gene discussed is CSF2; the disease is rheumatoid arthritis.